Breakthrough Status for Keytruda in Blood Cancer

22.04.2016 - US drugmaker Merck has gained Breakthrough Therapy Designation (BTD) from the US Food and Drug Administration (FDA) for Keytruda to treat patients with classical Hodgkin lymphoma...